Pramipexole

SIFROL 3.15 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 2.62 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 2.1 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 1.57 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 1.05 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.52 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.26 mg prolonged-release tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 1.1 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to:treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.7 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to:treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.35 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to:treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.18 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to:treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

SIFROL 0.088 mg tablets

SIFROL belongs to a group of medicines known as dopamine agonists, which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.SIFROL is used to:treat the symptoms of primary Parkinson?s disease. It... Mehr

Producer: Boehringer Ingelheim International GmbH

Therapeutic group: Anti-parkinson drugs

Pramipexole Teva 0.7 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in the treatment of Parkinson?s disease alone or in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs

Pramipexole Teva 0.18 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in the treatment of Parkinson?s disease alone or in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs

Pramipexole Teva 0.088 mg tablets

Pramipexole Teva is a dopamine agonistand works by stimulating dopamine receptors in the brain. In Parkinson?s disease levels of dopamine in the brain are low and Pramipexole Teva works by mimicking the action of dopamine.Pramipexole Teva is used in the treatment of Parkinson?s disease alone or in... Mehr

Producer: Teva Pharma B.V.

Therapeutic group: Anti-parkinson drugs

Oprymea 1.1 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to treat the symptoms of primary Parkinson's disease. It... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs

Oprymea 0.7 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to treat the symptoms of primary Parkinson's disease. It... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs

Oprymea 0.35 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to treat the symptoms of primary Parkinson's disease. It... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs

Oprymea 0.18 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to treat the symptoms of primary Parkinson's disease. It... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs

Oprymea 0.088 mg tablets

Oprymea belongs to a group of medicines known as dopamine agonists which stimulate dopamine receptors in the brain. Stimulation of the dopamine receptors triggers nerve impulses in the brain that help to control body movements.Oprymea is used to treat the symptoms of primary Parkinson's disease. It... Mehr

Producer: Krka, d.d., Novo mesto

Therapeutic group: Anti-parkinson drugs

Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK